Josee Dupuis, GSI faculty, BUSPH biostatistician and an international consortium (MAGIC) has identified new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the 13 newly discovered variants increase the risk of developing type 2 diabetes, the most common form of […]
GSI faculty member, Robert Green, MD, MPH, BUSM, professor of neurology, genetics and epidemiology participated in a panel discussion following the Boston premiere of “I Remember Better When I Paint,” an Alzheimer’s disease documentary on January 12th. Click here for more information. http://www.bu.edu/phpbin/news/releases/display.php?id=1994
GSI faculty member Miklos Sahin-Toth and colleague (Department of Molecular & Cell Biology, GSDM) have demonstrated that misfolding of mutant digestive enzymes also kills acinar cells —those that make and give out digestive enzymes. Click here for details. Szmola R, Sahin-Toth M. Pancreatitis-associated chymotrypsinogen C (CTRC) mutant elicits endoplasmic reticulum stress in pancreatic acinar cells. […]
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment. Click here for details. Wilson […]
The Genome Science Institute held its inaugural Research Symposium, an interdisciplinary research symposium that explores genetic and genomic science, in the Boston Medical Campus’ Hiebert Lounge on October 8, 2009. There were 63 abstracts submitted from students, post-doctoral fellows, and faculty from Institutions throughout the Boston area. Prizes were awarded in undergraduate, graduate and postdoctoral […]